FDA Investigator Dr. Gang Wang, PhD

Dr. Gang Wang, PhD has conducted inspections on 42 sites in 8 countries as of 21 Jan 2016. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
42
Last Inspection Date:
21 Jan 2016
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, China, Belgium, Germany, Hong Kong, Austria, Canada, United Kingdom of Great Britain and Northern Ireland
FDA Investigators that have inspected at least one site in common with Dr. Gang Wang, PhD:
Abby E Pelletier, Alia Legaux, Allison A Rodriguez, Amy Wyan Mai, Andrew A Leboeuf, Angela E Glenn, Angela K Shen, Anissa M Cheung, Anita R Michael, Ann Marie Montemurro, Anthony F Lorenzo, Arie C Menachem, Asamoah Asamoah, Azza Talaat, Bonita S Chester, Brandy D Brown, Brenda W Uratani, PhD, Brian D Nicholson, Brian L Belz, Brian R Yaun, Brooke K Higgins, Brooke K Seeman, Bruce H Mccullough, Burnell M Henry, Candice C Mandera, Candice J Cortes, Carl Lee, Carla J Lundi, Carolyn A Renshaw, Carrie L Doupnik, CDR Donald Ertel, CDR Ileana Barreto Pettit, CDR Sean T Creighton, CDR Thomas R Berry, PPh, Chad E Schmear, Charles I Ann, Christian D Lynch (CDL), Christopher D Leach, Christopher T Middendorf, Craig D Zagata, Cynthia Jim, CSO, Darrell E Luedtke, Darren S Brown, David A Oluwo, David J Gasparovich, David Keire, David Perkins, Debra I Love, Denise L Burosh, Dennis Cantellops Paite, Dennis L Doupnik, Destry M Sillivan, Dino A Fiegelstock, Djamila Harouaka, Dongping Dai, PhD, Douglas A Campbell, Douglas F Frazier, Dr. Robert C Horan, MD, Dr. Willie F Vann, PhD, Dr. Zhihao Qiu (Peter), PhD, Edmund F Mrak, Jr, Edward P Potter, Eileen A Liu, Eliezar Ramos, Elizabeth B Griffin, Ellen Huang, Emest F Bizjak, Eric L Dong, BS, Eric M Mueller, PharmD, Eric S Pittman, Esra Toussaint, Evelyn Taha, Fabian Nchaparro Rodriguez, Gene D Arcy, George J Flynn, George Pyramides, Gerald B Seaborn, Jr, Gifford Whitehurst, Jr, Gloria E Parra, Gregory R Dill, Hai Lient Phung, Harry J Brewer, Haruhiko Murata, Haydee B Romero, Helen B Ricalde, Helen R Bester, Irina Gaberman, Ivis L Negron, Jacqueline Mdiaz Albertini, James C Maclaughlin, James E Keller, PhD, James M Mason, James R Evans, James W Plucinski, Jane L Chang, Jeanne M Morris, Jeffrey D Meng, Jennifer L Schmidt, Jeremiah D Beckwith, Jesse A Vazquez, Jessica L Pressley, Jie He, Joan A Loreng, Joey V Quitania, John M Mcinnis, Jonathan G Matrisciano, Jonathan Mclnnis, Jonathan W Chapman, Jose A Lopez, Jose R Hernandez, Joseph George, Joseph L Despins, PhD, Julie D Bringger, Junho Pak, Justin A Boyd, Kara D Dobbin, Karen Emasley Joseph, Katherine Szestypalow, Keith Wonnacott, PhD, Kelly D Moore, Kenneth Nieves, Kevin D Kallander, Kevin P Foley, Kham Phommachanh, Kimberley A Hoefen, Kirsten L Vadheim, PhD, Krishna Ghosh, PhD, Kyran R Gibson, Lane V Christensen, PhD, Latorie S Jones, Laura M Howard, Laura Schankweiler, Laurie P Norwood, Laurimer Kuilan Torres, Lawrence Harmon, Jr, Lawrence J Stringer, LCDR Debra Emerson, Leena Thomas, Lequita M Mayhew, Leslie D Wagner, Linda F Murphy, Linda Thai, Lindsey M Schwierjohann, Lisa Mathew, Lorelei S Jarrell, Lori A Holmquist, LT Daveta L Bailey, LTJG Matthew R Palo, Lu Deng, Lucas B Leake, Luis A Dasta, Lynne M Dwyer, Maksim A Levenchuk, Marc A Jackson, Jr, Marcus A Ray, Margaret Torres Vazquez, Marie F Morin, Marijo B Kambere, PhD, Marion Michaelis, Mariza M Jafary, Mark E Frank, Marla A Cassidy, Mary P Padgett, Matthew B Casale, Matthew R Dionne, Maura Rooney, Melissa J Garcia, Mercy O Quagraine, Michael A Charles, Michael J Kuchta, Michael Merchlinsky, Michael R Goga, Michele L Forster, PhD, Michele L Glendenning, Mihaly S Ligmond, Mohammad Heidaran, PhD, Mra Davism, Nancy Haggard, Nawab A Siddiqui, Nebil A Oumer, Nicholas Z Lu, Nicole K Trudel, Nikisha M Bolden, Norman Wong, Omotunde O Osunsanmi, Pankaj H Amin, Paola S Barnett, Parul M Patel, Patricia A Mcilroy, Patrick C Klotzbuecher, Paul L Bellamy, Paula A Trost, Penny H Mccarver, Peter Abel, Peter E Baker, Phung Thien Nguyen, Pote Amin, Prabhu P Raju, Priscilla M Pastrana, Qiao Y Bobo, Qin Xu, Rachel C Harrington, Rachel T Evans, Randa Melhem, PhD, Rebecca K Olin, Richard W Thornton, Robert J Maffei, Robert Sausville, Robert W Fisher, Roberta W Cunningham, Robin Levis, PhD, Roger F Zabinski, Rose Ashley, Rose Xu, Russell K Riley, Sam Pepe, Sandra P White, Sarah B Tanksley, Shuang Tang, Sidney B Priesmeyer, Simone E Pitts, Solomon Yimam (SY), Stephen D Eich, Steven A Rubin, Steven J Thurber, Steven Oh, PhD, Steven P Donald, Susan M Jackson, Susan P Bruederle, Susan W Ting, Susanne M Richardson, MS RAC, Swati Verma, Taichun Qin, PhD, Tamara Brey, Temar Q Williams, Thai D Truong, That Q Dang, Theresa Kirkham (NMI), Thomas Finn, PhD, Thomas J Arista, Thomas R Withers, Tina S Roecklein, Todd M Stankewicz, Tonia F Bernard, Toyin B Oladimeji, Tracey L Harris, Truong Xuan Nguyen (Andy), Uduak M Inokon, Unnee Ranjan, Valerie Jgrecek Trinh, Vesna V Stanoyevitch, Viviana Matta, Walden H Lee, Wei Wang, PhD, Wella Wang, Xiaoping Guan, Yonggang Wang, PhD, Zhiping Ye, PhD, Zhongren Wu, Zi Qiang Gu

Dr. Gang Wang, PhD's Documents

Publish Date Document Type Title
February, 2007 FDA 483 Dendreon Corporation - Form 483, 2007-02-16
August, 2014 FDA 483 Nantong Tianlong Animal By-products Co., Ltd - Form 483, 2014-08-08
December, 2012 EIR Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. - EIR, 2012-12-21
December, 2012 FDA 483 Response Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. - Form 483R, 2012-12-21
October, 2015 FDA 483 Dongying Tiandong Pharmaceutical Co.,Ltd - Form 483, 2015-10-16
January, 2010 FDA 483 Dendreon Corporation - Form 483, 2010-01-29
March, 2015 EIR Zhejiang Hisun Pharmaceutical Co., Ltd. - EIR, 2015-03-07
December, 2012 FDA 483 Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. - Form 483, 2012-12-21
September, 2007 FDA 483 GlaxoSmithKline Biologicals SA - Form 483, 2007-09-21
February, 2007 EIR Dendreon Corporation - EIR, 2007-02-16
May, 2015 FDA 483 Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (FDF Site) - Form 483, 2015-05-12
March, 2014 FDA 483 Yibin Lihao Bio-technical Co., Ltd. - Form 483, 2014-03-05
January, 2010 FDA 483 Dendreon Corporation - Form 483, 2010-01-29
August, 2014 FDA 483 Changzhou Qianhong Bio Pharma Co., Ltd formulation plant - Form 483, 2014-08-01
April, 2011 FDA 483 Dendreon Pharmaceuticals LLC - Form 483, 2011-04-08
June, 2010 FDA 483 Regenerative Sciences, LLC - Form 483, 2010-06-16
January, 2010 EIR Dendreon Corporation - EIR, 2010-04-23
April, 2015 FDA 483 Yantai Dongcheng Biochemicals Co.,Ltd - Form 483, 2015-04-17
June, 2006 FDA 483 Indivior Manufacturing LLC - Form 483, 2006-06-02
January, 2013 FDA 483 Shenzhen Hepalink Pharmaceutical Group Co.,Ltd. - Form 483, 2013-01-15
March, 2015 FDA 483 Zhejiang Hisun Pharmaceutical Co., Ltd. - Form 483, 2015-03-07

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more